Results 11 to 20 of about 2,987,019 (361)
US Cardiology Review, 2020 Treatment of secondary (or functional) mitral regurgitation had traditionally been limited to optimal medical therapy because studies have failed to show a survival benefit with mitral valve surgery for this condition.
Suzanne J Baron
doaj +1 more source
Effectiveness of cost-effectiveness [PDF]
British Journal of Psychiatry, 2012 In their economic modelling, Barret & Byford[1][1] postulate that the intervention group will have a reoffending rate of 3% v . 5% in the non-intervention group, but give no evidence of this being the correct figure or even the justification for this being a reasonable estimate.
openaire +3 more sources
The probability of cost-effectiveness [PDF]
BMC Medical Research Methodology, 2002 The study of cost-effectiveness comparisons between competing medical interventions has led to a variety of proposals for quantifying cost-effectiveness. The differences between the various approaches can be subtle, and one purpose of this article is to clarify some important distinctions.We discuss alternative measures in the framework of individual ...
John Stevens, Anthony O'Hagan
openaire +4 more sources
Cost‐effectiveness analysis of computer‐based assessment [PDF]
, 2003 The need for more cost‐effective and pedagogically acceptable combinations of teaching and learning methods to sustain increasing student numbers means that the use of innovative methods, using technology, is accelerating.
Bull, Joanna, Loewenberger, Pauline
core +2 more sources
Cost‐effectiveness of asthma clinic approach in the management of chronic asthma in Australia
Australian and New Zealand Journal of Public Health, 2013 Objectives: To compare cost‐effectiveness of an asthma clinic that would provide education, promotion of self‐monitoring of symptoms, regular review of treatment by a medical practitioner and a written asthma action plan to current practice in Australia.
Vittal Mogasale, Theo Vos
doaj +1 more source
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis [PDF]
, 2003 OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness.
Abrams, K. +6 more
core +2 more sources
Australian and New Zealand Journal of Public Health, 2013 Objective: To estimate the potential impact on cardiovascular health of modifying dietary intake of saturated fat across the New Zealand population, and whether this would be appropriate and feasible.
Rachel H. Foster, Nick Wilson
doaj +1 more source
Open Heart, 2019 Objective To assess the potential impact of reduction in salt intake on the burden of cardiovascular disease (CVD) and premature mortality in Cameroon.Methods Using a multicohort proportional multistate life table model with Markov process, we modelled ...
J Lennert Veerman +2 more
doaj +1 more source
Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective. [PDF]
, 2017 Good health is a function of a range of biological, environmental, behavioral, and social factors. The consumption of quality health care services is therefore only a part of how good health is produced.
Martinez-Alvarez, Melisa +2 more
core +1 more source
Cost Effectiveness and Resource Allocation, 2023 Background Durvalumab plus gemcitabine and cisplatin has a significant clinical benefit for advanced biliary tract cancer (BTC). However, the high price of durvalumab warrants an exploration of the economics.
Qiuling Zhao +6 more
doaj +1 more source